Empagliflozin and Metformin Extended-Release Tablets and M-End Max D
Determining the interaction of Empagliflozin and Metformin Extended-Release Tablets and M-End Max D and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: empagliflozin / metformin
Brand name: Synjardy, Synjardy XR
Synonyms: Empagliflozin and metformin, Empagliflozin and Metformin
Generic Name: codeine / dexbrompheniramine / pseudoephedrine
Brand name: M-End Max D
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Empagliflozin and Metformin Extended-Release Tablets-M-End PE
- Empagliflozin and Metformin Extended-Release Tablets-M-End WC
- Empagliflozin and Metformin Extended-Release Tablets-M-Hist DM
- Empagliflozin and Metformin Extended-Release Tablets-M-Hist PD
- Empagliflozin and Metformin Extended-Release Tablets-M-M-R II
- Empagliflozin and Metformin Extended-Release Tablets-M-M-R II Vaccine
- M-End Max D-Empagliflozin and Metformin Tablets
- M-End Max D-Empliciti
- M-End Max D-Emsam
- M-End Max D-Emsam Transdermal
- M-End Max D-Emtricitabine
- M-End Max D-Emtricitabine and tenofovir